Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
albuterol HFA
(APC-2000) /
DMK Pharma
Welcome,
Profile
Billing
Logout
0 Diseases
0 Trials
0 Trials
2 News
|
|||||||||
albuterol HFA
(APC-2000) /
DMK Pharma
,
Benlysta
(belimumab) /
GSK
,
MD 2001
/
Aus Bio
Journal:
Trends in avascular necrosis and related arthroplasties in hospitalized patients with systemic lupus erythematosus and rheumatoid arthritis.
(Pubmed Central) - May 12, 2024
Fewer AVN-associated arthroplasties were noted for Black patients and those with Medicaid, indicating potential disparities. Further research should examine treatment differences impacting AVN and arthroplasty rates.
||||||||||
albuterol HFA
(APC-2000) /
DMK Pharma
,
Benlysta
(belimumab) /
GSK
,
MD 2001
/
Aus Bio
Trends, Sociodemographic and Clinical Factors Associated with Avascular Necrosis and Related Arthroplasties in Hospitalized Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
(Room 25A-C; in person) - Sep 23, 2023 - Abstract #ACRConvergence2023ACR_Convergence_2104;
There was an overall declining trend of AVN-associated arthroplasties in both SLE and RA. AVN hospitalizations were more likely to be younger and of the Black race.
||||||||||
albuterol HFA
(APC-2000) /
Adamis
,
MD 2001
/
Aus Bio
Colorectal Cancer Annual Percent Change Incidence Analysis in 40-49 and 50-54 Year-Olds Utilizing 2000-2016 SEER 18 Data and Stratified by Histology
(Exhibit Halls 3 and 4 (Street Level)) - Aug 8, 2019 - Abstract #ACG2019ACG_709;
Colon AC APC was 1.08% from 2000-2016, and rectal AC APC was 1.49% 2000-2016. Age 50-54 overall CRC APCs was 1.06% from 2000-2016.